BioAge Labs Inc.(us:BIOA)

3.58

-4.79%

Updated on 2025-04-02

Open:3.76
Close:3.58
High:3.76
Low:3.55
Prev Close:3.76
Volume:183835.00
Turnover:666061.19
Turnover Ratio:0.51%
Shares:35.85M
MarketCap:128.34M

About BioAge Labs Inc.

BioAge Labs, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapeutic products for metabolic diseases, such as obesity, by targeting the biology of human beings. It offers Azelaprag, a potential oral therapeutic for obesity, followed by several earlier-stage metabolic programs. The company was founded by Kristen Fortney and Eric Morgen on April 1, 2015 and is headquartered in Richmond, CA.

Company Name: BioAge Labs Inc.
Address: 1445A South 50th Street
Employees: 60
Fiscar Year: 12-31
IPO Date:
CIK: 1709941

View all SEC Filings

About

BioAge Labs, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapeutic products for metabolic diseases, such as obesity, by targeting the biology of human beings. It offers Azelaprag, a potential oral therapeutic for obesity, followed by several earlier-stage metabolic programs. The company was founded by Kristen Fortney and Eric Morgen on April 1, 2015 and is headquartered in Richmond, CA.
Address:1445A South 50th Street

Market Movers